Johnny John

Insider Reports History

Entity
Individual
Location
C/O Delcath Systems, Inc., 1633 Broadway, Suite 22 C, New York, New York
Signature
/s/ Gerard Michel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Johnny John:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DELCATH SYSTEMS, INC. SVP CLINICAL DEV & MED AFFAIRS Stock Option (Right to Buy) 46.8K Feb 8, 2023 Direct

Insider Reports Filed by Johnny John

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DCTH DELCATH SYSTEMS, INC. Jun 12, 2023 1 $0 4 Jun 21, 2023 Senior Vice President Clinical Development and Medical Affairs
DCTH DELCATH SYSTEMS, INC. Feb 8, 2023 1 $0 4 Jan 26, 2024 SVP CLINICAL DEV & MED AFFAIRS
DCTH DELCATH SYSTEMS, INC. Apr 4, 2022 0 $0 3/A Aug 15, 2022 Senior Vice President Clinical Development and Medical Affairs